Can We “Hedge” against the Development of Antiviral Resistance among Pandemic Influenza Viruses?

David K. Shay and Benjamin Ridenhour discuss a modeling study predicting that stockpiling a secondary antiviral for use early in a flu pandemic can forestall resistance to the primary stockpiled drug.

Detalles Bibliográficos
Autores principales: Shay, David K., Ridenhour, Benjamin J.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694987/
https://www.ncbi.nlm.nih.gov/pubmed/19564898
http://dx.doi.org/10.1371/journal.pmed.1000103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694987/
https://www.ncbi.nlm.nih.gov/pubmed/19564898
http://dx.doi.org/10.1371/journal.pmed.1000103

Ejemplares similares